Eucrisa (Crisaborole)

Crisaborole is a medicine used to treat mild to moderate eczema in adults and children 3 months and older. It is an ointment you rub onto the itchy, red skin. It works by calming the inflammation in the skin, and it is not a steroid.

Brand names:Eucrisa
Medication

What people taking Eucrisa (Crisaborole) report

Every report comes from a Lived member, sent anonymously.

Have you tried Eucrisa (Crisaborole) for Eczema?

NameHow it went

About Eucrisa (Crisaborole)

What It's For

Crisaborole, sold as Eucrisa, is a prescription ointment for mild to moderate atopic dermatitis, the most common type of eczema. It is approved for adults and for children as young as 3 months old. Atopic dermatitis makes the skin dry, itchy and inflamed, and it tends to come and go in flares. Crisaborole is not a steroid. It is one of several prescription options for eczema that is applied to the skin, alongside steroid creams and ointments, tacrolimus and pimecrolimus (nonsteroidal medicines called calcineurin inhibitors) and newer nonsteroidal creams. US dermatology guidelines recommend this type of medicine for adults with eczema. People often consider it when they want to rely less on steroids, or for thin, sensitive skin such as the face, neck and skin folds, where stronger steroids are generally avoided. Its approval covers mild to moderate eczema, not severe disease.

How It Works

Crisaborole belongs to a group of medicines called phosphodiesterase 4 (PDE4) inhibitors. PDE4 is an enzyme inside skin and immune cells that breaks down cAMP, a messenger molecule inside the cell. When crisaborole blocks PDE4, cAMP levels rise, and the cells produce fewer of the inflammatory signals that drive the redness and itch of eczema. Its prescribing information notes that exactly how this leads to improvement in eczema is not fully understood. Because it works through this route rather than as a steroid, crisaborole does not carry the risks of skin thinning, stretch marks or lightened skin color that come with long-term steroid use on the skin.

Dosage & Administration

Crisaborole comes as a 2% ointment in a tube. A thin layer is applied to the affected skin twice a day. Once the eczema has improved, the prescriber may suggest cutting back to once a day to help keep it under control. It is meant for the skin only and should not be used in the eyes, mouth or vagina. Regular moisturizing remains part of eczema care while using it.

Side Effects

The most common side effect is burning or stinging where the ointment is applied. In the main trials, about 4 in 100 people using crisaborole reported it, compared with 1 in 100 using the plain ointment base, though later studies in everyday practice found it in roughly 14 to 32 percent of users. If it is bothersome or does not settle, it is worth raising with the prescriber. Less often, crisaborole causes an allergic reaction in the skin, such as hives where it was applied or an allergic contact rash. Severe itching, swelling and redness, either where the ointment was applied or elsewhere on the body, can signal this kind of reaction. If that happens, stop using crisaborole and contact a clinician right away.

Interactions & Warnings

Anyone who has had an allergic reaction to crisaborole or to any ingredient in the ointment should not use it. Its prescribing information lists no specific drug interactions, but the prescriber should still know about other creams and ointments used on the same skin. Prescription eczema treatments applied to the skin, crisaborole included, are generally not used on skin with an active infection unless the infection is also being treated, so skin that looks infected should be checked first. There is too little information from pregnancy to know whether crisaborole carries any risk, although animal studies did not show birth defects at doses above those used in people. A small amount is absorbed into the bloodstream, and there is no information on breastfeeding. Anyone pregnant, planning pregnancy or breastfeeding should talk with the prescriber about whether it is the right choice.

What to Expect

In the trials that led to approval, results were measured after four weeks of twice-daily use. About a third of people using crisaborole reached clear or almost clear skin with a meaningful improvement, compared with 18 to 25 percent of people using the plain ointment base. Many people improve without clearing completely. In an indirect comparison of newer nonsteroidal creams, ruxolitinib cream (a JAK inhibitor applied to the skin) was more likely to produce clear or almost clear skin. Atopic dermatitis is long-lasting, and eczema treated only during flares often comes back. In a year-long study of people whose skin had responded, applying crisaborole once a day kept skin clear longer before the next flare (a median of 111 days, compared with 30 days on the ointment base) and led to fewer flares, so ongoing once-daily use is one option. If eczema has not reached the agreed goal after about six weeks, a change in plan is reasonable, such as a different or added skin treatment, light therapy, or a medicine taken by mouth or injection.

Questions to Ask Your Doctor

  1. 1.Why is crisaborole a better fit for my eczema than a steroid cream or another nonsteroidal option?
  2. 2.Should I use it only during flares, or once a day between flares to help prevent them?
  3. 3.What should I do if the burning or stinging does not settle after the first days?
  4. 4.How long should I use it before we decide whether it is working, and what would we try next?
  5. 5.Is it a reasonable choice if I am pregnant, planning a pregnancy or breastfeeding?

Last reviewed • Oct 2026

Educational content, not medical advice.